Viveve Medical, Inc. (NASDAQ:VIVE) – B. Riley boosted their FY2016 earnings per share (EPS) estimates for Viveve Medical in a note issued to investors on Wednesday. B. Riley analyst G. Chodaczek now forecasts that the brokerage will post earnings of ($2.15) per share for the year, up from their prior forecast of ($2.20). B. Riley has a “Buy” rating and a $10.00 price objective on the stock. B. Riley also issued estimates for Viveve Medical’s Q4 2016 earnings at ($0.49) EPS, Q2 2017 earnings at ($0.43) EPS, Q3 2017 earnings at ($0.44) EPS, Q4 2017 earnings at ($0.42) EPS and FY2017 earnings at ($1.80) EPS.

“Viveve Medical, Inc. to Post FY2016 Earnings of ($2.15) Per Share, B. Riley Forecasts (VIVE)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/02/17/viveve-medical-inc-to-post-fy2016-earnings-of-2-15-per-share-b-riley-forecasts-vive.html.

Viveve Medical (NASDAQ:VIVE) opened at 4.92 on Friday. Viveve Medical has a 12-month low of $4.02 and a 12-month high of $10.50. The stock has a 50 day moving average of $5.00 and a 200 day moving average of $6.22.

“Viveve Medical, Inc. to Post FY2016 Earnings of ($2.15) Per Share, B. Riley Forecasts (VIVE)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/02/17/viveve-medical-inc-to-post-fy2016-earnings-of-2-15-per-share-b-riley-forecasts-vive.html.

A hedge fund recently raised its stake in Viveve Medical stock. HighTower Advisors LLC increased its position in Viveve Medical, Inc. (NASDAQ:VIVE) by 39.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 910,632 shares of the company’s stock after buying an additional 259,861 shares during the period. HighTower Advisors LLC’s holdings in Viveve Medical were worth $6,574,000 at the end of the most recent quarter. 54.43% of the stock is currently owned by institutional investors and hedge funds.

Viveve Medical Company Profile

Viveve Medical, Inc, formerly PLC Systems, Inc, designs, develops, manufactures and markets medical devices for the non-invasive treatment of vaginal laxity. The Company’s Viveve Treatment is a non-invasive solution for vaginal laxity that is performed in approximately 30 minutes, in a physician’s office.

5 Day Chart for NASDAQ:VIVE

Receive News & Stock Ratings for Viveve Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical Inc. and related stocks with our FREE daily email newsletter.